Day: February 7, 2023

TEMECULA, Californie, 07 févr. 2023 (GLOBE NEWSWIRE) — Nikkiso Clean Energy & Industrial Gases Group (le « Groupe »), qui fait partie de Nikkiso Co., Ltd (Japon), opérant sous Cryogenic Industries, Inc. (État-Unis d’Amérique), a finalisé l’acquisition de la société Cryotec Anlagenbau GmbH (Cryotec), située à Wurzen, Saxe, Allemagne. Le montant n’a pas été divulgué. Société opérant […]

TEMECULA, Californie, 07 févr. 2023 (GLOBE NEWSWIRE) — Nikkiso Clean Energy & Industrial Gases Group (le « Groupe »), qui fait partie de Nikkiso Co., Ltd (Japon), opérant sous Cryogenic Industries, Inc. (État-Unis d’Amérique), a finalisé l’acquisition de la société Cryotec Anlagenbau GmbH (Cryotec), située à Wurzen, Saxe, Allemagne. Le montant n’a pas été divulgué. Société opérant…

Read More “Nikkiso Clean Energy & Industrial Gases Group finalise l’acquisition de Cryotec Anlagenbau GmbH, à Wurzen, en Allemagne” »

TEMECULA, Califórnia, Feb. 07, 2023 (GLOBE NEWSWIRE) — O Clean Energy and Industrial Gases Group (“Grupo”) da Nikkiso Cryogenic parte da Nikkiso Co., Ltd (Japão), operando sob a Cryogenic Industries, Inc. (EUA), finalizou a aquisição da Cryotec Anlagenbau GmbH (Cryotec), de Wurzen, Saxônia, Alemanha por um valor não revelado. Uma empresa global de engenharia e […]

TEMECULA, Califórnia, Feb. 07, 2023 (GLOBE NEWSWIRE) — O Clean Energy and Industrial Gases Group (“Grupo”) da Nikkiso Cryogenic parte da Nikkiso Co., Ltd (Japão), operando sob a Cryogenic Industries, Inc. (EUA), finalizou a aquisição da Cryotec Anlagenbau GmbH (Cryotec), de Wurzen, Saxônia, Alemanha por um valor não revelado. Uma empresa global de engenharia e…

Read More “Nikkiso Clean Energy & Industrial Gases Group Finaliza a Aquisição da Cryotec Anlagenbau GmbH, Wurzen, Alemanha” »

Carl D Francis takes the helm at medtech group focused on reversal of diabetes, NASH, and obesity LONDON, Feb. 07, 2023 (GLOBE NEWSWIRE) — Today Keyron, the medical technology group focused on reversing type 2 diabetes, non-alcoholic steatohepatitis (NASH), and obesity via an innovative medical device platform, announced the appointment of Carl D Francis as Chief […]

Carl D Francis takes the helm at medtech group focused on reversal of diabetes, NASH, and obesity LONDON, Feb. 07, 2023 (GLOBE NEWSWIRE) — Today Keyron, the medical technology group focused on reversing type 2 diabetes, non-alcoholic steatohepatitis (NASH), and obesity via an innovative medical device platform, announced the appointment of Carl D Francis as Chief…

Read More “Keyron appoints new Chief Executive Officer” »